UniProt ID | DPOLB_HUMAN | |
---|---|---|
UniProt AC | P06746 | |
Protein Name | DNA polymerase beta | |
Gene Name | POLB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 335 | |
Subcellular Localization | Nucleus. Cytoplasm. Cytoplasmic in normal conditions. Translocates to the nucleus following DNA damage. | |
Protein Description | Repair polymerase that plays a key role in base-excision repair. Has 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity that removes the 5' sugar phosphate and also acts as a DNA polymerase that adds one nucleotide to the 3' end of the arising single-nucleotide gap. Conducts 'gap-filling' DNA synthesis in a stepwise distributive fashion rather than in a processive fashion as for other DNA polymerases.. | |
Protein Sequence | MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
36 | Phosphorylation | VSQAIHKYNAYRKAA HHHHHHHHHHHHHHH | 7.29 | - | |
39 | Phosphorylation | AIHKYNAYRKAASVI HHHHHHHHHHHHHHH | 14.70 | - | |
41 | Ubiquitination | HKYNAYRKAASVIAK HHHHHHHHHHHHHHH | 35.31 | 19713937 | |
44 | Phosphorylation | NAYRKAASVIAKYPH HHHHHHHHHHHHCCC | 20.93 | 2040602 | |
49 | Phosphorylation | AASVIAKYPHKIKSG HHHHHHHCCCCCCCH | 11.10 | - | |
55 | Phosphorylation | KYPHKIKSGAEAKKL HCCCCCCCHHHHHCC | 46.86 | 2040602 | |
61 | Ubiquitination | KSGAEAKKLPGVGTK CCHHHHHCCCCCCHH | 67.95 | 21362556 | |
67 | Phosphorylation | KKLPGVGTKIAEKID HCCCCCCHHHHHHHH | 19.51 | 23532336 | |
72 | Acetylation | VGTKIAEKIDEFLAT CCHHHHHHHHHHHHH | 46.57 | 23954790 | |
81 | Ubiquitination | DEFLATGKLRKLEKI HHHHHHCHHHHHHHH | 40.54 | 19713937 | |
81 | Acetylation | DEFLATGKLRKLEKI HHHHHHCHHHHHHHH | 40.54 | 25953088 | |
83 | Methylation | FLATGKLRKLEKIRQ HHHHCHHHHHHHHHC | 45.02 | 16600869 | |
104 | Phosphorylation | INFLTRVSGIGPSAA HHHHHHHCCCCHHHH | 22.77 | 28555341 | |
113 | Ubiquitination | IGPSAARKFVDEGIK CCHHHHHHHHHHHHH | 45.04 | - | |
141 | Ubiquitination | HHQRIGLKYFGDFEK HHHHHCHHHHCCHHH | 33.06 | - | |
141 | Sumoylation | HHQRIGLKYFGDFEK HHHHHCHHHHCCHHH | 33.06 | - | |
141 | Sumoylation | HHQRIGLKYFGDFEK HHHHHCHHHHCCHHH | 33.06 | - | |
148 | 2-Hydroxyisobutyrylation | KYFGDFEKRIPREEM HHHCCHHHHCCHHHH | 56.47 | - | |
148 | Ubiquitination | KYFGDFEKRIPREEM HHHCCHHHHCCHHHH | 56.47 | - | |
152 | Methylation | DFEKRIPREEMLQMQ CHHHHCCHHHHHHHH | 50.57 | 16600869 | |
176 | Phosphorylation | VDSEYIATVCGSFRR CCHHHHHHHHHHHHC | 13.53 | 28348404 | |
180 | Phosphorylation | YIATVCGSFRRGAES HHHHHHHHHHCCCCC | 15.51 | 28348404 | |
206 | Ubiquitination | SFTSESTKQPKLLHQ CCCCCCCCCHHHHHH | 74.09 | - | |
230 | Acetylation | FITDTLSKGETKFMG EEECCCCCCCCEEEE | 64.97 | 25953088 | |
230 | Ubiquitination | FITDTLSKGETKFMG EEECCCCCCCCEEEE | 64.97 | - | |
243 | Phosphorylation | MGVCQLPSKNDEKEY EEEEECCCCCCCCCC | 53.32 | 24719451 | |
244 | Ubiquitination | GVCQLPSKNDEKEYP EEEECCCCCCCCCCC | 67.49 | - | |
250 | Phosphorylation | SKNDEKEYPHRRIDI CCCCCCCCCCCEEEE | 18.53 | 17360941 | |
258 | Methylation | PHRRIDIRLIPKDQY CCCEEEEEECCCCCE | 23.87 | 115488043 | |
297 | Phosphorylation | GFTINEYTIRPLGVT CCEEEEEEEEECCEE | 12.34 | 24719451 | |
322 | Phosphorylation | SEKDIFDYIQWKYRE CCCHHHHHHHHHHCC | 5.58 | 29083192 | |
327 | Phosphorylation | FDYIQWKYREPKDRS HHHHHHHHCCCCCCC | 19.76 | 29083192 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPOLB_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00987 | Cytarabine |
loading...
Methylation | |
Reference | PubMed |
"Arginine methylation regulates DNA polymerase beta."; El-Andaloussi N., Valovka T., Toueille M., Steinacher R., Focke F.,Gehrig P., Covic M., Hassa P.O., Schaer P., Huebscher U.,Hottiger M.O.; Mol. Cell 22:51-62(2006). Cited for: METHYLATION AT ARG-83 AND ARG-152 BY PRMT6, AND MUTAGENESIS OF ARG-83AND ARG-152. | |
Ubiquitylation | |
Reference | PubMed |
"USP47 is a deubiquitylating enzyme that regulates base excisionrepair by controlling steady-state levels of DNA Polymerase beta."; Parsons J.L., Dianova I.I., Khoronenkova S.V., Edelmann M.J.,Kessler B.M., Dianov G.L.; Mol. Cell 41:609-615(2011). Cited for: FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION AT LYS-41; LYS-61 ANDLYS-81, DEUBIQUITINATION BY USP47, AND INTERACTION WITH USP47. | |
"Ubiquitin ligase ARF-BP1/Mule modulates base excision repair."; Parsons J.L., Tait P.S., Finch D., Dianova I.I., Edelmann M.J.,Khoronenkova S.V., Kessler B.M., Sharma R.A., McKenna W.G.,Dianov G.L.; EMBO J. 28:3207-3215(2009). Cited for: SUBCELLULAR LOCATION, UBIQUITINATION AT LYS-41; LYS-61 AND LYS-81, ANDMUTAGENESIS OF LYS-41; LYS-61 AND LYS-81. |